Jasper Therapeutics (JSPR) 10-Q2021 Q1 Quarterly report

Filed: 24 May 21, 4:20pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	Coll freshman V bad

New words: accretion, amortization, amortized, Ample, authoritative, beginning, beneficial, black, Carlo, categorized, classification, complex, component, Concurrently, contemplated, cost, criteria, currency, customary, develop, embedded, enhancing, entirety, equivalent, expanded, experience, fairly, FASB, foreign, freestanding, gain, hedge, Hedging, highest, identification, implemented, improve, improved, indexed, indirectly, input, Jasper, led, light, literature, lowest, member, merge, million, model, Monte, noncash, original, permanent, pertaining, PIPE, priority, professional, remediation, requisite, retrospective, satisfaction, scope, settlement, simplify, Simulation, subscribe, Subscription, subsidiary, Subtopic, surviving, training, unadjusted, wholly

Removed: absolute, acceleration, adverse, adversely, afforded, aid, Alex, amounting, assist, Azar, bank, bearing, borrow, breach, characterized, China, community, compared, competitive, continued, continuing, covenant, cover, default, delaying, demand, depend, dilute, diluting, dilution, disease, economic, emerge, emergency, flexibility, foreclosure, global, granted, greater, health, highly, Human, inability, increase, increased, International, limit, maintenance, outbreak, ownership, participating, payment, personnel, planning, posed, predicted, prevailing, preventing, principal, Promissory, recent, removal, renegotiation, resignation, responding, restrict, restricting, resulted, Secretary, seeking, senior, Similarly, spread, strain, subordinate, surfaced, treat, ultimately, unavailable, vulnerability, widespread, world, worldwide, Wuhan

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

JSPR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Amplitude Healthcare Acquisition Corporation (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Kenneth Clifford, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

Date: May 24, 2021	By:	/s/ Kenneth Clifford
		Kenneth Clifford
		Chief Financial Officer
		(Principal Financial and Accounting Officer)